Your Health. Your Family. Your Choice.
Administered by: Unknown Purchased by: ?
Life Threatening? No
Write-up: Death; A regulatory report, was received from a physician concerning a 76-year-old male patient who received Moderna''s COVID-19 vaccine (mRNA-1273) and experienced death. The patient''s medical history included type 2 diabetes mellitus, arterial hypertension, obesity, mesenteric ischemia, lumbovertebral syndrome, and PTCA and stenting of the mesenteric artery and celiac trunk. Concomitant medications included chondroitin sulfate sodium, amlodipine besilate/perindopril arginine, canagliflozin, metformin hydrochloride/sitagliptin phosphate, and clopidogrel bisulfate. On 23 JAN 2021, the patient received their first of two planned doses of mRNA-1273 (Batch: 300042460) intramuscularly in left arm for prophylaxis of COVID-19 infection. On 20 FEB 2021, the patient received their second of two planned doses of mRNA-1273 (Batch: 300042723) intramuscularly in left arm for prophylaxis of COVID-19 infection. On 22 FEB 2021, the patient died. Cause of death was unknown. Plans for an autopsy was not provided. The action taken with mRNA-1273 in response to the event was not applicable. The reporter considered the death unlikely related to mRNA-1273.; Reporter''s Comments: This case concerns a 76-year-old, male, with multiple comorbidities, who experienced a serious (fatal) unexpected event of death (unknown cause). Death occurred 2 days after receiving 2nd dose of mRNA-1273 (Lot# 300042723). Based on the current available information, the event was considered unrelated to the study medication in agreement with the reporter''s assessment. The advance age and multiple co-morbidities may remain as risk factors. No further information has been requested.; Reported Cause(s) of Death: Unknown cause of death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166